| Next 10 |
Ad
MBOT News and Press Microbot Medical Inc.
News | Microbot Medical Inc. (NASDAQ:MBOT)
-
2023-09-18 13:13:33 ET For further details see: TTOO, ASTR and MBOT among mid-day movers
-
BRAINTREE, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) is honored to announce the continuous growing global recognition of its LIBERTY ® Robotic Surgical System, to be presented in an abstract at the Annual Congress of the Cardiovascular and Interventio...
-
2023-08-15 09:33:39 ET Microbot Medical ( NASDAQ: MBOT ) said on Tuesday that it had signed a manufacturing agreement with B.Y. Medimor. MBOT added that the agreement governs the manufacturing of its LIBERTY robotic surgical system. Press Release F...
-
BRAINTREE, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic Surgical System, the first single-use endovascular robotic system, announces another step in its commitment to advance the commercialization processes of LIBER...
-
HINGHAM, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic Surgical System, the first single-use endovascular robotic system, today announces the expansion of its global team of experts supporting the Company as scientif...
-
MBOT - Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe
HINGHAM, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic Surgical System, the first single-use endovascular robotic system, today announced the first steps towards its planned European market clearance, by engaging wit...
-
HINGHAM, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic Surgical System, the first single-use endovascular robotic surgical system, today announced that Irene Bargellini, M.D., an interventional radiologist and Chair ...
-
HINGHAM, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic Surgical System, the first single-use endovascular robotic surgical system, today announced the successful completion of an extended pre-clinical study held by l...
-
Microbot Medical Closes Fourth Registered Direct Offering Priced At-The-Market under Nasdaq Rules HINGHAM, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it closed its previously announced registered direct offering for the purchase an...
-
2023-06-27 10:59:07 ET Pre-clinical medical device company, Microbot Medical ( NASDAQ: MBOT ) stock price is down 14% enters agreement for the purchase and sale of ~624K shares at a purchase price of $3.25 per share. The company will issue unregistered series D prefer...
Stock Information
Microbot Medical Inc. Company Name:
MBOT Stock Symbol:
NASDAQ Market:
Microbot Medical Inc. Website:
Ad
-
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday. Fresh Tracks T...
-
BRAINTREE, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ:MBOT) is honored to announce the continuous growing global re...
-
BRAINTREE, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) is honored to announce the continuous growing global recognition of its LIBERTY ® Robotic Surgical System, to be presented in an abstract at the Annual Congress of the Cardiovascular and Interventio...